Literature DB >> 7142379

Developmental expression of neurotypy revealed by immunocytochemistry with monoclonal antibodies.

M E Goldstein, N H Sternberger, L A Sternberger.   

Abstract

Adult and developing rat cerebella were stained immunocytochemically with six neuron-specific monoclonal antibodies obtained from spleen cells of BALB/c mice immunized with hypothalamus. Monoclonal peroxidase-antiperoxidase complex was used in the staining procedure. In the adult, three different staining patterns were seen with these antibodies. The general patterns have been designated as (1) neurofibrillar, (2) perikaryal-neurofribillar, and (3) synapse-associated. In addition, each antibody within a designated group showed a different immunocytochemical distribution. Some antibodies reacted widely, for example, with many neuronal perikarya and fibers, and their distribution increased with the development of the brain. Other antibodies had a more restricted distribution and stained only some structures within an area or pathway. To account for this type of restriction of distribution, we propose that there may be microheterogeneity of some of the antigens visualized and have called this microheterogeneity 'neurotypy'. A second type of restriction was also observed. With several antibodies a loss of staining occurred in the adult cerebellum in structures that had reacted during early development. These differences in staining probably reflect developmental regulation of the antigens (neurotypes).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7142379     DOI: 10.1016/0165-5728(82)90023-6

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

1.  The neurofilament antibody RT97 recognises a developmentally regulated phosphorylation epitope on microtubule-associated protein 1B.

Authors:  M Johnstone; R G Goold; I Fischer; P R Gordon-Weeks
Journal:  J Anat       Date:  1997-08       Impact factor: 2.610

2.  Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ.

Authors:  L A Sternberger; N H Sternberger
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

3.  Microheterogeneity ("neurotypy") of neurofilament proteins.

Authors:  M E Goldstein; L A Sternberger; N H Sternberger
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

4.  Changes in insulin and transferrin requirements of pure brain neuronal cultures during embryonic development.

Authors:  Y Aizenman; M E Weichsel; J de Vellis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

5.  Aberrant neurofilament phosphorylation in Alzheimer disease.

Authors:  N H Sternberger; L A Sternberger; J Ulrich
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

6.  Infantile neurodegenerative disease with neuronal accumulation of phosphorylated neurofilaments.

Authors:  C A Wiley; S Love; R R Skoglund; P W Lampert
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

7.  Human teratomas express differentiated neural antigens. An immunohistochemical study with anti-neurofilament, anti-glial filament, and anti-myelin basic protein monoclonal antibodies.

Authors:  J Q Trojanowski; W F Hickey
Journal:  Am J Pathol       Date:  1984-06       Impact factor: 4.307

8.  Vasculocentric Axonal NfH in Small Vessel Disease.

Authors:  Adam Anad; Miriam K Barker; Jessica A Katanga; Konstantinos Arfanakis; Leslie R Bridges; Margaret M Esiri; Jeremy D Isaacs; Sonja Prpar Mihevc; Anthony C Pereira; Julie A Schneider; Atticus H Hainsworth
Journal:  J Neuropathol Exp Neurol       Date:  2022-02-24       Impact factor: 3.685

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.